Enzastaurin, an investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of brain cancer. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include enzastaurina and Kinenza. Its PubChem CID is 176167.
Enzastaurin
| CAS No | 170364-57-5 |
|---|---|
| Molecular Formula | C32H29N5O2 |
| Molecular Weight | 515.6 g/mol |
| Synonyms | 3-(1-methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Enzastaurin, an investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of brain cancer.
The listed CAS number is 170364-57-5.
The listed molecular formula is C32H29N5O2.
The listed molecular weight is 515.6 g/mol.
3-(1-methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione.
The source lists enzastaurina and Kinenza.